Icovamenib
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Icovamenib, covering 2026-04-08 to 2026-04-08. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy [Phase 2]